These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9184962)

  • 1. Expectations and fears of women regarding two methods of prenatal screening.
    Esen UI; Olajide F
    Int J Gynaecol Obstet; 1997 May; 57(2):193-4. PubMed ID: 9184962
    [No Abstract]   [Full Text] [Related]  

  • 2. Women's opinions on the offer and use of prenatal diagnosis.
    Tymstra TJ; Bajema C; Beekhuis JR; Mantingh A
    Prenat Diagn; 1991 Dec; 11(12):893-8. PubMed ID: 1725210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for Down's syndrome.
    Gocze PM; Arany A; Freeman DA
    N Engl J Med; 1992 Dec; 327(27):1951; author reply 1952-3. PubMed ID: 1280772
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome of pregnancies with elevation of both maternal serum alpha-fetoprotein and human chorionic gonadotropin.
    Kuller JA; Sellati LE; Chescheir NC; Helwick JJ; Lincoln-Boyea B; Boor-Smith C; McCoy MC; Katz VL
    Am J Perinatol; 1995 Mar; 12(2):93-7. PubMed ID: 7540011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type III congenital cystic adenomatoid malformation of the lung detected through maternal serum screening positive for Down's syndrome.
    Chen CP; Chuang CY; Chang YC; Tzen CY
    Acta Obstet Gynecol Scand; 1997 Apr; 76(4):378-9. PubMed ID: 9174436
    [No Abstract]   [Full Text] [Related]  

  • 6. [Maternal serum markers of fetal trisomy 21].
    Muller F; Bussières L; Chevallier B
    Presse Med; 1995 Sep; 24(27):1265-9. PubMed ID: 7501610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perception of risk in relation to ultrasound screening for Down's syndrome during pregnancy.
    Georgsson Ohman S; Grunewald C; Waldenström U
    Midwifery; 2009 Jun; 25(3):264-76. PubMed ID: 17920172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting antepartum stillbirth.
    Smith GC
    Clin Obstet Gynecol; 2010 Sep; 53(3):597-606. PubMed ID: 20661044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical use of a quadruple biochemical marker in the prediction of obstetric complications].
    Aranda Gallegos JE; Barrón Vallejo J; de la Luna Pérez LG; Corona de Lau QC; Kably Ambe A
    Ginecol Obstet Mex; 1999 Jan; 67():18-22. PubMed ID: 10085605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcome and long term prognosis in 868 children born after second trimester amniocentesis for maternal serum positive triple test screening and normal prenatal karyotype.
    Witters I; Legius E; Devriendt K; Moerman P; Van Schoubroeck D; Van Assche A; Fryns JP
    J Med Genet; 2001 May; 38(5):336-8. PubMed ID: 11403044
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal ultrasound findings in women with low serum risk for trisomy.
    Nwosu EC; Walkinshaw SA; Pilling DW; Farquharson RG
    Lancet; 1993 Jan; 341(8839):253-4. PubMed ID: 7678317
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of gestation dating in Down's screening.
    Worthington DJ
    Ann Clin Biochem; 1997 Jan; 34 ( Pt 1)():1-2. PubMed ID: 9022881
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biochemical and ultrasonic screening of chromosomal aneuploidies in the second trimester of pregnancy].
    Török O; Veress L; Szabó M; Zsupán I; Buczkó Z; Bolodár A; Harsányi A; Tóth Z
    Orv Hetil; 1997 Jan; 138(3):123-7. PubMed ID: 9064624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for Down's syndrome--results of a 3-year study].
    Kimlová I; Procházková
    Ceska Gynekol; 1996 Apr; 61(2):75-8. PubMed ID: 8689003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prioritization and the "triple"-test in prenatal diagnosis].
    Pedersen KM
    Ugeskr Laeger; 1999 Dec; 161(50):6901. PubMed ID: 10643374
    [No Abstract]   [Full Text] [Related]  

  • 18. Results and views of women in population-wide pregnancy screening for trisomy 21 in east Finland.
    Heikkilä A; Ryynänen M; Kirkinen P; Saarikoski S
    Fetal Diagn Ther; 1997; 12(2):93-6. PubMed ID: 9218949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for trisomy 21 using biological markers and ultrasonography].
    Rozenberg P; Philippe HJ; Perdu M; Nisand I
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3 Suppl):187-9. PubMed ID: 9471457
    [No Abstract]   [Full Text] [Related]  

  • 20. Prenatal screening for trisomy 18.
    Reynolds TM; Wierzbicki A
    Prenat Diagn; 1996 May; 16(5):475-6; author reply 477-8. PubMed ID: 8844010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.